We are live on ! Find out more
ASXC

Asensus Surgical, Inc.

Delisted

ASXC was delisted on the 21st of August, 2024.

132 hedge funds and large institutions have $272M invested in Asensus Surgical, Inc. in 2018 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 15

203% more capital invested

Capital invested by funds: $89.7M → $272M (+$182M)

40% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 25

39% more funds holding

Funds holding: 95132 (+37)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

48% less call options, than puts

Call options by funds: $7.75M | Put options by funds: $14.8M

Holders
132
Holders Change
+37
Holders Change %
+38.95%
% of All Funds
3.02%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
52
Increased
35
Reduced
25
Closed
15
Calls
$7.75M
Puts
$14.8M
Net Calls
-$7.06M
Net Calls Change
-$6.86M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$43M +$22.8M +625,575 +468%
SHI
2
SV Health Investors
Massachusetts
$32.9M
Vanguard Group
3
Vanguard Group
Pennsylvania
$32.5M +$5.12M +140,628 +33%
JP Morgan Chase
4
JP Morgan Chase
New York
$30.5M -$823K -22,594 -4%
AC
5
Aisling Capital
New York
$27.9M -$9.81M -269,230 -35%
State Street
6
State Street
Massachusetts
$14.4M +$8.89M +244,139 +2,624%
GXMC
7
Global X Management Company
New York
$11.2M +$7.2M +197,806 New
AIM
8
Artemis Investment Management
United Kingdom
$5.66M +$3.68M +101,159 New
MCM
9
Masters Capital Management
Georgia
$5.39M -$7.74M -212,576 -69%
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$5.37M +$196K +5,390 +6%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$5.05M +$1.37M +37,514 +73%
Goldman Sachs
12
Goldman Sachs
New York
$3.95M -$160K -4,381 -6%
IBT
13
International Biotechnology Trust
United Kingdom
$3.82M
EAM
14
Eagle Asset Management
Florida
$3.45M +$1.34M +36,791 +153%
Morgan Stanley
15
Morgan Stanley
New York
$3.33M +$1.93M +52,956 +912%
UBS Group
16
UBS Group
Switzerland
$3.05M -$579K -15,903 -23%
Northern Trust
17
Northern Trust
Illinois
$2.61M +$926K +25,414 +124%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$2.19M +$990K +27,181 +237%
New York State Common Retirement Fund
19
New York State Common Retirement Fund
New York
$2.18M +$1.4M +38,396 New
AQR Capital Management
20
AQR Capital Management
Connecticut
$1.76M +$1.13M +31,047 New
TEE
21
Tibra Equities Europe
United Kingdom
$1.63M +$109K +2,981 +12%
TCIM
22
TIAA CREF Investment Management
New York
$1.49M +$959K +26,323 New
Charles Schwab
23
Charles Schwab
California
$1.41M +$904K +24,815 New
EGI
24
EAM Global Investors
California
$1.35M +$870K +23,882 New
Deutsche Bank
25
Deutsche Bank
Germany
$1.33M +$235K +6,449 +38%

ASXC Hedge Fund Activity: Q2 2018 in Review

132 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q2 2018, worth a combined $272M — up 203% from $89.7M a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new ASXC positions and 15 closed out — a net gain of 37 holders — while 35 added to existing stakes and 25 trimmed.

The largest buyer was BlackRock, adding an estimated $22.8M. The largest seller was Aisling Capital, cutting an estimated $9.81M.

  • 132 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q2 2018, up from 95 in Q1 2018.
  • Funds reported $272M of Asensus Surgical, Inc. stock for Q2 2018, up 203% quarter-over-quarter.
  • 52 funds opened new Asensus Surgical, Inc. positions in Q2 2018 and 15 closed out, a net change of +37 holders.
  • The largest Asensus Surgical, Inc. buyer in Q2 2018 was BlackRock, an estimated $22.8M added.
  • The largest Asensus Surgical, Inc. seller in Q2 2018 was Aisling Capital, an estimated $9.81M sold.

Based on aggregated 13F filings for Q2 2018.